
Drug chains need to differentiate trends from fads
By Kristin Hornberger, executive vice president and practice leader in wellness and homecare at Circana
By Kristin Hornberger, executive vice president and practice leader in wellness and homecare at Circana
By Jacqueline Flam, senior vice president of beauty, drug and OTC for NielsenIQ
By Dave Wendland, vice president of strategic relations and a member of the HRG owner group
By Todd Huseby, partner at Kearney, a global management consulting firm, and leads its Consumer Healthcare practice
By Andrea Leigh, founder and chief executive officer of the Allume Group
By Lari Harding, senior vice president of industry affairs and strategic partnerships at Inmar Intelligence
Brian Owens, managing director of strategy and insights at BAV Group.
By Darpan Seth, chief executive officer of Nextuple, an omnichannel order management advisory and software firm
Das Pattathil, chief executive officer of OnePint.ai
By Bradley Keefer, chief revenue officer at Keen Decision Systems
By Deborah Weinswig, founder and chief executive officer of Coresight Research
By David Weinfeld, cofounder and chief executive officer of Screenverse
By Grace Mahas and Jonathon Brown, director of content and chief growth officer, respectively, at Trend Hunter
David Pinto writes that his long-time friend Jim Whitman can never be replaced once he retires from NACDS. "It’s not just what he did, how often he did it, or how effectively he did it. Rather, it has been the unfailing presence of the man himself."
President Trump’s fluctuating tariff policies have complicated the decision-making process for executives.
By Tom Furphy, chief executive officer and managing director of Consumer Equity Partners